|
1
|
Mendenhall WM, Mendenhall CM, Werning JW,
Reith JD and Mendenhall NP: Cutaneous angiosarcoma. Am J Clin
Oncol. 29:524–528. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bernstein JM, Irish JC, Brown DH,
Goldstein D, Chung P, Razak ARA, Catton C, Gilbert RW, Gullane PJ
and O'Sullivan B: Survival outcomes for cutaneous angiosarcoma of
the scalp versus face. Head Neck. 39:1205–1211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ward JR, Feigenberg SJ, Mendenhall NP,
Marcus RB Jr and Mendenhall WM: Radiation therapy for angiosarcoma.
Head Neck. 25:873–878. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shin JY, Roh SG, Lee NH and Yang KM:
Predisposing factors for poor prognosis of angiosarcoma of the
scalp and face: Systematic review and meta-analysis. Head Neck.
39:380–386. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miki Y, Tada T, Kamo R, Hosono MN, Tamiya
H, Shimatani Y, Tsutsumi S, Ogino R and MIKI Y: Single
institutional experience of the treatment of angiosarcoma of the
face and scalp. Br J Radiol. 86:201304392013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fujisawa Y, Yoshino K, Kadono T, Miyagawa
T, Nakamura Y and Fujimoto M: Chemoradiotherapy with taxane is
superior to conventional surgery and radiotherapy in the management
of cutaneous angiosarcoma: A multicentre, retrospective study. Br J
Dermatol. 171:1493–1500. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ito T, Uchi H, Nakahara T, Tsuji G, Oda Y,
Hagihara A and Furue M: Cutaneous angiosarcoma of the head and
face: A single-center analysis of treatment outcomes in 43 patients
in Japan. J Cancer Res Clin Oncol. 142:1387–1394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sasaki R, Soejima T, Kishi K, Imajo Y,
Hirota S, Kamikonya N, Murakami M, Kawabe T, Ejima Y, Matsumoto A
and Sugimura K: Angiosarcoma treated with radiotherapy: Impact of
tumor type and size on outcome. Int J Radiat Oncol Biol Phys.
52:1032–1040. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohguri T, Imada H, Nomoto S, Yahara K,
Hisaoka M, Hashimoto H, Tokura Y, Nakamura K, Shioyama Y, Honda H,
et al: Angiosarcoma of the scalp treated with curative radiotherapy
plus recombinant interleukin-2 immunotherapy. Int J Radiat Oncol
Biol Phys. 61:1446–1453. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ogawa K, Takahashi K, Asato Y, Yamamoto Y,
Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, et al:
Treatment and prognosis of angiosarcoma of the scalp and face: A
retrospective analysis of 48 patients. Br J Radiol. 85:e1127–e1133.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perez MC, Padhya TA, Messina JL, Jackson
RS, Gonzalez RJ, Bui MM, Letson GD, Cruse CW, Lavey RS, Cheong D,
et al: Cutaneous angiosarcoma: A single-institution experience. Ann
Surg Oncol. 20:3391–3397. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Patel SH, Hayden RE, Hinni ML, Wong WW,
Foote RL, Milani S, Wu Q, Ko SJ and Halyard MY: Angiosarcoma of the
scalp and face: The Mayo Clinic experience. JAMA Otolaryngol Head
and Neck Surg. 141:335–340. 2015. View Article : Google Scholar
|
|
13
|
Pawlik TM, Paulino AF, Mcginn CJ, Baker
LH, Cohen DS, Morris JS, Rees R and Sondak VK: Cutaneous
angiosarcoma of the scalp: A multidisciplinary approach. Cancer.
98:1716–1726. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Suzuki G, Yamazaki H, Takenaka H, Aibe N,
Masui K, Kimoto T, Takekawa K, Nakashima A, Takenaka T, Asai J, et
al: Definitive radiation therapy for angiosarcoma of the face and
scalp. In Vivo. 30:921–926. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fata F, O'Reilly E, Ilson D, Pfister D,
Leffel D, Kelsen DP, Schwartz GK and Casper ES: Paclitaxel in the
treatment of patients with angiosarcoma of the scalp or face.
Cancer. 86:2034–2037. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Isogai R, Kawada A, Aragane Y and Tezuka
T: Successful treatment of pulmonary metastasis and local
recurrence of angiosarcoma with docetaxel. J Dermatol. 31:335–341.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo
T and Nishigori C: Docetaxel: A therapeutic option in the treatment
of cutaneous angiosarcoma: Report of 9 patients. Cancer.
110:648–651. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Penel N, Bui BN, Bay JO, Cupissol D,
Ray-Coquard I, Piperno-Neumann S, Kerbrat P, Fournier C, Taieb S,
Jimenez M, et al: Phase II trial of weekly paclitaxel for
unresectable angiosarcoma: The ANGIOTAX Study. J Clin Oncol.
26:5269–5274. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van der Graaf WT, Blay JY, Chawla SP, Kim
DW, Bui-Nguyen B, Casali PG, Schöffski P, Aglietta M, Staddon AP,
Beppu Y, et al: Pazopanib for metastatic soft-tissue sarcoma
(PALETTE): A randomised, double-blind, placebo-controlled phase 3
trial. Lancet. 379:1879–1886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sindhu S, Gimber LH, Cranmer L, McBride A
and Kraft AS: Angiosarcoma treated successfully with anti-PD-1
therapy-a case report. J Immunother Cancer. 5:582017. View Article : Google Scholar : PubMed/NCBI
|
